International variation in chemotherapy use in cancer - Authors' reply.

Barclay, Matthew E; McPhail, Sean; Johnson, Shane A; Swann, Ruth; Lyratzopoulos, Georgios

Barclay, Matthew E; McPhail, Sean; Johnson, Shane A; Swann, Ruth; Lyratzopoulos, Georgios.

Afiliação

Barclay ME; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London WC1E 7HB, UK.
McPhail S; National Disease Registration Service, NHS England, Leeds, UK.
Johnson SA; Cancer Intelligence, Cancer Research UK, London, UK.
Swann R; National Disease Registration Service, NHS England, Leeds, UK; Cancer Intelligence, Cancer Research UK, London, UK.
Lyratzopoulos G; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London WC1E 7HB, UK; National Disease Registration Service, NHS England, Leeds, UK. Electronic address: y.lyratzopoulos@ucl.ac.uk.

Lancet Oncol ; 25(6): e232, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38821093

Assuntos

Neoplasias; Humanos; Neoplasias/tratamento farmacológico; Antineoplásicos/uso terapêutico; Antineoplásicos/efeitos adversos; Padrões de Prática Médica/normas

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google